Patrick F. Kiser

4.3k citations

86 papers · 3.5k indexed · h-index 33

Impact in

Microbiology top 0.5%
- Reproductive tract infections research
Molecular Medicine top 0.5%
- Hydrogels: synthesis, properties, applications

Papers in

Virology 26
- HIV Research and Treatment 26
Microbiology 33
- Reproductive tract infections research 33

Co-authors: David Needham Glynn Wilson Gary Eichenbaum Sidney A. Simon Todd J. Johnson Meredith R. Clark David R. Friend Alamelu Mahalingam
Journals: Journal of Pharmaceutical Sciences (7 papers)Macromolecules (7 papers)Antimicrobial Agents and Chemotherapy (6 papers)AIDS Research and Human Retroviruses (6 papers)Antiviral Research (5 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Patrick F. Kiser

85 papers receiving 3.4k citations

Peers

Countries citing papers authored by Patrick F. Kiser

Since Specialization

Citations

This map shows the geographic impact of Patrick F. Kiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick F. Kiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick F. Kiser more than expected).

Fields of papers citing papers by Patrick F. Kiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick F. Kiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick F. Kiser. The network helps show where Patrick F. Kiser may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Patrick F. Kiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick F. Kiser Line = papers co-authored together Patrick F. Kiser links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Conjoint Analysis of User Acceptability of Sustained Long-Acting Pre-Exposure Prophylaxis for HIV AIDS Research and Human Retroviruses ·Catherine Atkin, 雄二南島, Richard T. D’Aquila, George J. Greene, Alex Carballo‐Diéguez, Rebecca Giguere, Christine Tagliaferri Rael, Patrick F. Kiser, Thomas J. Hope	2021	8
2	A Subcutaneous Implant of Tenofovir Alafenamide Fumarate Causes Local Inflammation and Tissue Necrosis in Rabbits and Macaques Antimicrobial Agents and Chemotherapy ·Francesca Cavalletti, 段永强, Marta Castañeda-Pomeda, 雄二南島, Ronald S. Veazey, Mark A. Marzinke, Ni Wayan Sri Widari, 要子武野, Lakmini Widanapathirana, Sebald ANR Verkuijl, M. Melissa Peet, D. Karunakaran, Brooke Grasperge, Georgina L Dobek, Jakšić-Horvat Kornelija, Thomas J. Hope, Patrick F. Kiser	2019	52
3	Qualitative Consumer Research on Acceptance of Long-Acting Pre-Exposure Prophylaxis Products Among Men Having Sex with Men and Medical Practitioners in the United States AIDS Research and Human Retroviruses ·Bobby J. Calder, Catherine Atkin, 雄二南島, Richard T. D’Aquila, George J. Greene, Alex Carballo‐Diéguez, Rebecca Giguere, Patrick F. Kiser, Thomas J. Hope	2018	16
4	Long-term direct visualization of passively transferred fluorophore-conjugated antibodies Journal of Immunological Methods ·Jeffrey R. Schneider, Ann M. Carias, Ю И Молев, Gianguido C. Cianci, Patrick F. Kiser, Ronald S. Veazey, Thomas J. Hope	2017	12
5	A Dose Ranging Pharmacokinetic Evaluation of IQP-0528 Released from Intravaginal Rings in Non-Human Primates Pharmaceutical Research ·Francesca Cavalletti, Ryan S. Teller, Priya Srinivasan, Jining Zhang, Amy Martin, Marta Castañeda-Pomeda, James M. Smith, Patrick F. Kiser	2017	8
6	Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract PLoS Pathogens ·Ann M. Carias, 始関修一, Angela J. Fought, Verena Beuck, Meegan R. Anderson, Bo Fu, Michael D. McRaven, Mandira Sapkota, Tara Henning, Ellen N. Kersh, James M. Smith, Lara Pereira, Katherine Butler, Roseli Fischmann, R. Michael Hendry, Patrick F. Kiser, Ronald S. Veazey, Thomas J. Hope	2016	23
7	Perceptibility and the “Choice Experience”: User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design AIDS Research and Human Retroviruses ·Kate M. Guthrie, Shira Dunsiger, Sara Vargas, Joseph L. Fava, Сергій ВИЛКОВ, Rochelle K. Rosen, Patrick F. Kiser, Erna M. Kojic, Daisuke Nose, David F. Katz	2016	17
8	A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring AIDS ·Marla J. Keller, Pedro M. M. Mesquita, Mark A. Marzinke, Ryan S. Teller, Sammy A. Hankaoui, Jessica Atrio, Yungtai Lo, Guan-chao Qin, Sujatha Srinivasan, David N. Fredricks, Lorna K. Rabe, Peter L. Anderson, Craig W. Hendrix, Patrick F. Kiser, Betsy C. Herold	2015	23
9	An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission Journal of Pharmaceutical Sciences ·曹茂通, Justin T. Clark, Rafael Sánchez Anillo, Todd J. Johnson, Karen W. Buckheit, T. Tebeică, Daniel H. Appella, Robert W. Buckheit, Patrick F. Kiser	2015	17
10	Designing Preclinical Perceptibility Measures to Evaluate Topical Vaginal Gel Formulations: Relating User Sensory Perceptions and Experiences to Formulation Properties AIDS Research and Human Retroviruses ·Kathleen M. Morrow, Joseph L. Fava, Rochelle K. Rosen, Sara Vargas, Сергій ВИЛКОВ, Erna M. Kojic, Patrick F. Kiser, Daisuke Nose, Felice Eugenio Agr��	2013	26
11	A Perspective on Progress and Gaps in HIV Prevention Science AIDS Research and Human Retroviruses ·Patrick F. Kiser, Pedro M. M. Mesquita, Betsy C. Herold	2012	7
12	Design of Tenofovir–UC781 Combination Microbicide Vaginal Gels Journal of Pharmaceutical Sciences ·Patrick F. Kiser, Alamelu Mahalingam, J Fabián, Eric M. Smith, Festo Damian, Jennifer J. Peters, David F. Katz, Hoda M. Elgendy, Meredith R. Clark, David R. Friend	2012	27
13	Development of a Combination Microbicide Gel Formulation Containing IQP-0528 and Tenofovir for the Prevention of HIV Infection Journal of Pharmaceutical Sciences ·Anthony S. Ham, 曹茂通, Lianjun Shi, Karen W. Buckheit, Mohammed Tabaa, Angela Graupmann-Kuzma, Alex Crittenden, G. van Muijen, Patrick F. Kiser, Robert W. Buckheit	2012	22
14	Pharmacokinetics of UC781-loaded intravaginal ring segments in rabbits: a comparison of polymer matrices Drug Delivery and Translational Research ·Meredith R. Clark, Patrick F. Kiser, 白希初, Christopher McConville, Karl Malcolm, David R. Friend	2011	16
15	Advances in microbicide vaginal rings Antiviral Research ·Karl Malcolm, Heliodora Díaz Padrón, Patrick F. Kiser, Joseph Romano, Thomas J. Smith	2010	137
16	Approaches to improve the stability of the antiviral agent UC781 in aqueous solutions International Journal of Pharmaceutics ·Festo Damian, J Fabián, David R. Friend, Patrick F. Kiser	2010	15
17	Temperature and pH Sensitive Hydrogels: An Approach Towards Smart Semen-Triggered Vaginal Microbicidal Vehicles Journal of Pharmaceutical Sciences ·Kavita M. Gupta, 夏光利, Choji Davou Nyap, Tomas Schietecat, Derek H. Owen, David F. Katz, Patrick F. Kiser	2006	61
18	オリゴ乳酸エステル及びオリゴグリコール酸エステルから成る対称生分解性架橋剤を含むポリ(HPMA)ヒドロゲルの設計と性能 Polymer preprints ·Patrick F. Kiser, Florence Pinet, Gary Eichenbaum, David Needham, Richard E. Buller	2000	1
19	Theoretical calculations on calcium channel drugs: Is electron transfer involved mechanistically? Chemico-Biological Interactions ·Peter Kovacic, W. Daniel Edwards, Nicholas R. Natale, Rajagopalan Sridhar, Patrick F. Kiser	1990	12
20	Are Reduction Potentials of Antifungal Agents Relevant to Activity? Pharmaceutical Research ·Peter Kovacic, Patrick F. Kiser, Benjamin A. Feinberg	1990	16

About Patrick F. Kiser

Patrick F. Kiser is a scholar working on Virology, Microbiology, Molecular Medicine, Infectious Diseases and Pharmaceutical Science, having authored 86 papers that have together received 3.5k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (39 papers), Reproductive tract infections research (33 papers), HIV Research and Treatment (26 papers), Hydrogels: synthesis, properties, applications (12 papers), Adolescent Sexual and Reproductive Health (11 papers), HIV/AIDS drug development and treatment (9 papers), HIV, Drug Use, Sexual Risk (7 papers) and Advanced Drug Delivery Systems (6 papers). The work is most often cited by research in Microbiology (854 citations), Molecular Medicine (667 citations), Virology (620 citations), Pharmaceutical Science (423 citations) and Infectious Diseases (1.1k citations). Patrick F. Kiser has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include David Needham, Glynn Wilson, Gary Eichenbaum, Sidney A. Simon, Todd J. Johnson, Meredith R. Clark, David R. Friend, Alamelu Mahalingam, Justin T. Clark and Melissa C. Hanson. Their work appears in journals such as Journal of Pharmaceutical Sciences, Macromolecules, Antimicrobial Agents and Chemotherapy, AIDS Research and Human Retroviruses and Antiviral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact